MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2017 International Congress

    Rapidly progressive dementia and parkinsonism caused by a cortical dural AV fistula: a case report

    T. Weissfeld, D. Kremens, J. McCall (Philadelphia, PA, USA)

    Objective: To report the case of a 75-year-old woman with rapidly progressive dementia and parkinsonism caused by a cortical dural AV fistula Background: Vascular malformations…
  • 2017 International Congress

    Decisional capacity for Goals of Care in Parkinson’s Disease with Cognitive Concerns

    M. Abu Snineh, R. Camicioli, J. Miyasaki (Jerusalen, Israel)

    Objective: We sought to assess decisional capacity (DC) for Goals of Care (GOC) using the MacArthur Competence Assessment Tool (MacCAT) for Parkinson’s disease (PD) patients…
  • 2017 International Congress

    Effects of continuous apomorphine infusion on motor and nonmotor symptoms in Parkinson’s disease without cognitive deterioration

    J.-F. Houvenaghel, S. Drapier, J. Duprez, D. Drapier, M. Vérin (Rennes, France)

    Objective: The aim of the present study was to investigate the influence of apomorphine pump in Parkinson’s disease (PD) on motor and nonmotor symptoms, including…
  • 2017 International Congress

    Mitochondrial DNA variants function as potential genetic risk factors for Parkinson disease

    X. Zhang, T. Li, Z.-F. Fan, B.-L. Hu, J.-H. Zhu (Wenzhou, China)

    Objective: To understand whether mtDNA variants contribute to the susceptibility to sporadic PD. Background: It is well-recognized that mitochondrial (mt) dysfunction is involved in the…
  • 2017 International Congress

    Characterization of Noncoding Variant(s) Driving Genome-Wide Association of the PARK10 Locus in Autopsy-Proven Parkinson Disease and Controls.

    J. Vance, K. Nuytemans, D. Gveric, L. Gomez, G. Beecham, E. Martin, W. Scott (Miami, FL, USA)

    Objective: Confirm the PARK10 locus as a major GWAS locus in autopsy-confirmed (AC) PD and AC controls and identify potential noncoding variants driving the association. …
  • 2017 International Congress

    Electrophysiological markers for emotional and cognitive impairment in Parkinson’s disease

    N. Dissanayaka, T. Au, A. Angwin, J. O'Sullivan, G. Byrne, P. Silburn, R. Marsh, G. Mellick, D. Copland (Brisbane, Australia)

    Objective: This study aims to identify markers for emotional and cognitive dysfunctions in Parkinson’s disease (PD) using non-invasive electroencephalography (EEG). This study investigates event related…
  • 2017 International Congress

    What strategies do Parkinson’s disease patients use for getting out of bed in the early morning? Preliminary results from home video analysis of 22 patients.

    J. Sringean, C. Anan, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To classify PD patients’ getting out of bed strategies using home video analysis. Background: Getting out of bed represents a major difficulty of early…
  • 2017 International Congress

    Validation of the MDS Research Criteria for Prodromal Parkinson’s Disease: longitudinal assessment in a REM sleep behavior disorder (RBD) cohort

    S.-M. Fereshtehnejad, J. Montplaisir, A. Pelletier, J.-F. Gagnon, D. Berg, R. Postuma (Montreal, QC, Canada)

    Objective: 1) To calculate diagnostic accuracy of the Movement Disorder Society (MDS) prodromal criteria to predict conversion to Parkinson’s disease (PD) or dementia with Lewy…
  • 2017 International Congress

    End of Life Care in Parkinson’s Disease

    S. Mole, S. Jackson (Exeter, United Kingdom)

    Objective: We aim to identify the current practice at the Royal Devon & Exeter NHS trust of managing Patients with PD at the end of…
  • 2017 International Congress

    Prognosis and end-of-life status after emergency admissions in patients with Parkinson disease: a Japanese single center retrospective study

    K. Ikeda, K. Takahashi, K. Kawasaki, T. Furuya, A. Miyake, T. Mitsufuji, T. Fukuoka, Y. Ito, Y. Nakazato, N. Araki, T. Yamamoto (Iruma-gun, Saitama-ken, Japan)

    Objective: To investigate the status after the emergency admissions and to determine the cause and location of death in patients with Parkinson disease (PD). Background:…
  • « Previous Page
  • 1
  • …
  • 280
  • 281
  • 282
  • 283
  • 284
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley